Investing.comCodex · 实盘不做把握 7/10不做原因:无增量信息
北京时间·🕒 发布 09-01 20:44:28·⟳ 抓取 09-01 20:45:44 +1m16s·⚡ 决策 09-02 01:20:37 +4h34m·55.8 天前
Frazier完成从ResMed收购MatrixCare，经济条款此前已披露
本次新闻只是收购交割完成；核心交易金额、资产范围、战略用途和对ResMed的财务量级均已在2026-07-07公告和后续SEC文件披露，缺少足以改变ResMed短线定价的新事实。
📄 原文Investing.com↗ 原文
Frazier Healthcare completes acquisition of MatrixCare from ResMed
Fed hike bets, oil rally and Japan yields - what’s moving markets SEATTLE - Frazier Healthcare Partners completed its a…
不做 ResMed（RMD.US）
不做ResMed（RMD.US）：9月1日交割完成是7月已公告出售MatrixCare的程序性落地，核心金额和财务影响已披露，缺少新增预期差。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
MatrixCare出售给Frazier对ResMed方向上偏聚焦主业和资本回报，但该交易在2026-07-07已作为4.90亿美元现金交易披露，FY2026收入和利润基数也已进入年报；9月1日完成交割并任命MatrixCare CEO不改变ResMed的收入、利润或回购预期，因此不构成新的可执行交易催化。
消息传播链
- ResMed首次公告已签署出售MatrixCare给Frazier的协议，交易预计在FY2027第一季度完成。
- Reuters报道称交易现金对价为4.90亿美元，ResMed拟将净收益用于股东回报和一般公司用途。
- Frazier宣布完成收购MatrixCare并任命Jonathan Lujan为MatrixCare CEO；未披露新的交易金额或ResMed财务影响。
关键理由
- 4.90亿美元出售款相对ResMed FY2026约56.53亿美元收入和大型市值不是新的增量信息。
- MatrixCare FY2026约2.20亿美元收入、约5500万美元非GAAP营业利润的剥离影响此前已披露。
主要风险
- 若ResMed随后单独公告超预期ASR规模或关闭交易带来会计收益，可能重新形成独立催化。
- 未使用实时行情，因此本次不输出任何入场价或追价交易。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-08-18 · 影响 weakens
SEC年报已披露交易金额和MatrixCare财务贡献，削弱把交割新闻作为新利好的依据。
检索:ResMed MatrixCare sale $490 million FY2026 revenue operating profit SEC 2026 原文 ↗ - 做空前查反向 · 来源 web · 日期 2026-09-01 · 影响 none
交割完成本身不是对ResMed的新增经营损害，且出售资产符合此前聚焦主业叙事，不支持做空。
检索:ResMed completes MatrixCare sale Frazier terms undisclosed September 2026 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例不足未改变结论；本次直接按已披露交易完成且无增量信息处理为不做。
方向:未使用先例定方向，因为当前结论由无新增事实和程序性交割决定。
涨幅量级:无可用于校准的新增事件幅度。
形态:不适用。
工具执行结果 · 成功 2 · 降级 0 · 失败 0 · 取消 0
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
原文全文
展开原文 · 1,782 字
Fed hike bets, oil rally and Japan yields - what’s moving markets
SEATTLE - Frazier Healthcare Partners completed its acquisition of MatrixCare from ResMed (NYSE & ASX:RMD), according to a press release statement issued today.
MatrixCare provides cloud-based electronic health record and revenue cycle management solutions for out-of-hospital care settings, including skilled nursing, senior living, home health, hospice, and life plan communities. The company serves more than 15,000 providers and has received the Best in KLAS award for multiple years.
The transaction includes MatrixCare and related software offerings sold under the MatrixCare brand, including Healthcare First, Citus, and home health and hospice solutions.
Jonathan Lujan was appointed Chief Executive Officer of MatrixCare concurrent with the closing. Lujan previously served as Chief Executive Officer of Sight Growth Partners and held executive positions at Lifeline Vascular Care at DaVita and Surgical Information Systems. He also worked at GE Healthcare and J.P. Morgan’s Healthcare Investment Banking Group.
"Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, and home health and hospice providers," said Ryan Lucero, General Partner at Frazier Healthcare Partners.
Frazier Healthcare Partners is a Seattle-based private equity firm focused on the healthcare industry. Founded in 1991, the firm has raised over $11 billion of capital and invested in more than 200 companies.
The financial terms of the transaction were not disclosed in the announcement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
SEATTLE - Frazier Healthcare Partners completed its acquisition of MatrixCare from ResMed (NYSE & ASX:RMD), according to a press release statement issued today.
MatrixCare provides cloud-based electronic health record and revenue cycle management solutions for out-of-hospital care settings, including skilled nursing, senior living, home health, hospice, and life plan communities. The company serves more than 15,000 providers and has received the Best in KLAS award for multiple years.
The transaction includes MatrixCare and related software offerings sold under the MatrixCare brand, including Healthcare First, Citus, and home health and hospice solutions.
Jonathan Lujan was appointed Chief Executive Officer of MatrixCare concurrent with the closing. Lujan previously served as Chief Executive Officer of Sight Growth Partners and held executive positions at Lifeline Vascular Care at DaVita and Surgical Information Systems. He also worked at GE Healthcare and J.P. Morgan’s Healthcare Investment Banking Group.
"Frazier has spent several years evaluating the post-acute care technology sector and believes MatrixCare has established itself as a leading platform serving skilled nursing, senior living, and home health and hospice providers," said Ryan Lucero, General Partner at Frazier Healthcare Partners.
Frazier Healthcare Partners is a Seattle-based private equity firm focused on the healthcare industry. Founded in 1991, the firm has raised over $11 billion of capital and invested in more than 200 companies.
The financial terms of the transaction were not disclosed in the announcement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。